The cyberattack on Change has some cancer centers scrambling to find money for chemotherapy to avoid delaying treatment, but Change said it plans to have cancer services up and running this week, The New York Times reported March 5.
The Latest
A research team based at Morehouse School of Medicine in Atlanta has been selected as one of five teams globally to receive a multimillion-dollar award, which it will put toward studies to address cancer disparities among populations of African descent.
The FDA approved a new drug for first-line lung cancer treatment.
Miami-based Sylvester Comprehensive Cancer Center received a $50 million gift from Kenneth Griffin, founder and CEO of Citadel and founder of Griffin Catalyst.
Uterine cancer is the only cancer that has seen survival rates continuously fall in the last 40 years, but research published March 4 in the British Journal of Cancer suggests that using a medication to block a protein called Galectin-3…
Denosumab, a bone-modifying agent for cancer treatment, is being overused and costing Medicare more than $43 million each year, a recent Memorial Sloan Kettering study found.
Cancer patients who undergo surgery and have a behavioral health disorder have higher odds of a complication, prolonged length of stay and 90-day readmission, a recent study found.
The American Cancer Society has launched a national training and credentialing program to support cancer institutions in advancing patient navigation services.
Five of the top 10 oncology hospitals in the world are based in the U.S., according to Newsweek's 2024 "World's Best Specialized Hospitals" list.
Tampa, Fla.-based Moffitt Cancer Center named Jonathan Zager, MD, physician of the year.